CASSIE KRAUSE: Open Payments
NPI 1487915559 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 5 payments from 5 companies in 2025. Trend: 2023 $24 · 2024 $95 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $149 |
| TG Therapeutics, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $18 |
| CSL Behring | 1 | $15 |
Products named: AMVUTTRA, BRIUMVI, Actemra, Hizentra.
Industry payments across NE — which companies pay providers there.
